This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Inclusion in Action: Breaking Open the Leaky Pipeline to Create Pathways & Design Spaces that Improve Representation
Dr. Idalid “Ivy” Franco is works in the Department of Radiation Oncology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute at Harvard Medical School. The effect of oppression on workforce incorporation Dr. Franco’s presentation began by looking at the context and long-standing hurdles to recruitment, retention, and professional success of a workforce that resembles the US population. This historical context started with American slavery, followed by years of segregation, laying a foundation of decades of judgement and mistreatment. This lies ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Adapting NCI’s Clinical Trials System to a Changed Clinical Research Environment
Dr. James H. Doroshow is Deputy Director for Clinical and Translational Research at the National Cancer Institute (NCI). This plenary session occurred at 8:30 am., Thursday, Feb. 22, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. COVID’s impact on cancer clinical trials Dr. Doroshow’s presentation began by discussing the initial and continuing effects of the pandemic environment on cancer clinical trials. From the start of the pandemic, several aspects of clinical trials were altered, including informed consent and in-person study activities. One major ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Advances in Evidence-based Digital Solutions for Supporting Latino Cancer Patients
Dr. John Piette is Professor in the School of Public Health, and Director of the Center for Managing Chronic Disease (CMCD) at the University of Michigan. Cognitive behavioral therapy Dr. Piette’s presentation began by discussing how cognitive behavioral therapy (CBT) can be used for Latino cancer patients. CBT is the most common evidence-based intervention for cancer patients struggling with mental health, symptoms, stress, and sleep. In cancer patients, CBT has been shown to help manage distress and pain, alleviate insomnia, manage fear of cancer recurrence, and reduce emotional distress and ...
Dr. Amelie G. Ramirez, leader of Salud America!, appeared alongside other breast cancer experts and oncologists at the 2024 San Antonio Breast Cancer Symposium. The San Antonio Breast Cancer Symposium is an annual conference that delivers important on breast cancer research, therapy, biology, diagnosis, and prevention for an international audience of thousands of virtual and in-person attendees. During the symposium, physicians and researchers learn by attending lectures given by experts in clinical, translational, and basic research, discussions, forums, and presentations, including poster presentations. While in attendance Ramirez brought awareness to the need for more cancer prevention and getting information out to groups that lack participation in clinical ...
Dr. Patricia Chalela, a researcher at the Institute for Health Promotion Research (IHPR) at UT Health San Antonio, has been named the IBC Foundation Endowed Professorship in Health Promotion Research. The International Bancshares Corporation (IBC) Foundation is a private foundation affiliated with IBC and its subsidiary banks. It is dedicated to supporting charities that enrich the community and improve the health and wellness of people in Texas and Oklahoma. The foundation made a $2 million donation that established four endowed professorships at UT Health San Antonio. Dr. Chalela's endowment, which is for $500,000, aims to help her advance novel research in health promotion. "I am deeply honored and sincerely grateful to be nominated as the recipient of the IBC Foundation ...
Dr. Amelie G. Ramirez, leader of Salud America! at UT Health San Antonio, joined other cancer experts to discuss participation in clinical trials, research, and healthcare on a podcast episode for the Cancer History Project by The Cancer Letter. The episode features: Dr. Ramirez
Dr. Luis Carvajal-Carmona, University of California, Davis
Dr. Edith Perez, Mayo Clinic
Dr. Marcia Cruz-Correa, University of Puerto Rico Comprehensive Cancer Center
Dr. Yolanda Sanchez, University of New Mexico Comprehensive Cancer Center
Dr. Ruben Mesa, Atrium Health Wake Forest Baptist Comprehensive Cancer Center (moderator) The group explores cancer and clinical care among people with different backgrounds. “The pipeline issue continues to be a huge issue for us,” said Ramirez, ...
Dr. Amelie G. Ramirez, leader of Salud America!, joined a KSAT News town hall on Oct. 8, 2024, to share insights on a growing effort to address cancer in majority-Latino South Texas. The event, “Revolutionizing Cancer Care for South Texans: A New Era of Treatment,” was hosted by KSAT anchor Stephania Jimenez. It featured Ramirez, Dr. Mark Bonnen, chief medical officer at the Mays Cancer Center at UT Health San Antonio, and Jeff Flowers, chief executive officer at the UT Health San Antonio Multispecialty & Research Hospital. Ramirez shared about the state of cancer and the need to address the non-medical drivers of health in South Texas. She also urged cancer survivors to join the Avanzando Caminos study. The study aims to enroll 1,500 Latino cancer survivors in South ...
Dr. Francisco G. Cigarroa, UT Health San Antonio’s Malú and Carlos Alvarez Center for Transplantation, Hepatobiliary Surgery and Innovation Director, still remembers the greatest gift he’s ever received. It didn’t come in the form of an award, a plaque, certificate, or even a baked good. It came from a 6-year-old patient. Cigarroa was astonished when the girl he had operated on a few months prior opened her mouth to sing a song meant especially for him. He cried. “To this day it’s still the most beautiful gift I’ve ever gotten, and she had the voice of an angel,” Cigarroa recalled. “Sometimes the greatest gifts come in the most unexpected ways.” Cigarroa has held many titles over the course of his illustrious career, including being ...
In 2024, an estimated 195,300 cancer cases will be diagnosed in U.S. Latinos, according to Cancer Facts & Figures for Hispanic/Latino People 2024-2026. This makes it important that cancer treatments work for Latinos. Clinical trials – studies with volunteers that explore ways to find, prevent, and treat diseases, like cancer – are a treatment option that could help people. With clinical trial participation in mind, Dr. Eneida Nemecek and her team at the Oregon Health and Science University (OHSU) Knight Cancer Institute created Proyecto Mi Opción, a series of Spanish-language videos that tackle different cancer-related topics. Watch the videos!
The Lack of Latinos in Clinical Trial Research
Latinos face several challenges when it comes to cancer including access to ...
